artificial intelligence

With CardioCare already in its portfolio, egnite plans to develop more solutions that harness data science to improve patient outcomes and reduce healthcare costs.
By  Mallory Hackett 02:00 pm February 10, 2021
A new digital healthcare company called egnite launched Wednesday with the goal of leveraging advanced technologies and analytics to improve health outcomes for structural heart-disease patients. Egnite originates from the CardioCare platform developed by Edwards Lifesciences, which is already deployed at over 50 hospitals and health systems across the country. The platform is designed to manage...
Experts at CES 2021 discuss how to overcome the barrier for trust in something that is hard to understand and visualize.
By  Mallory Hackett 12:40 pm January 12, 2021
By this point in time, artificial intelligence and machine learning are deployed by healthcare organizations for almost every aspect of the care journey. From clinical decision-making support to automating the revenue cycle, AI has become an integral tool in healthcare. A problem remains in how clinicians, staff and patients can trust something that they can’t see and oftentimes don’t understand...
By  Dave Muoio 01:24 pm December 1, 2020
Alphabet subsidiary DeepMind has cracked a decades-old protein-folding challenge with an artificial intelligence system that could eventually help identify new treatments for diseases, among other nonmedical uses. "We have been stuck on this one problem – how do proteins fold up? – for nearly 50 years," John Moult, cofounder and chair of the Critical Assessment of protein Structure Prediction (...
An image of the AutoML Entity Extraction for Healthcare tool
By  Dave Muoio 01:55 pm November 11, 2020
Google Cloud pulled back the curtain yesterday on two artificial intelligence tools designed to help healthcare and life science organizations scan and analyze large volumes of unstructured text, the Healthcare Natural Language API and AutoML Entity Extraction for Healthcare. The first of these two offerings looks to automatically extract common trends or other insights from medical records notes...
By  Dave Muoio 12:28 pm October 21, 2020
The past couple of days have seen a handful of artificial intelligence algorithms for radiology imaging analysis receive 510(k) clearances from the FDA. Two of these, from Quantib and Ezra, are focused on the relatively untouched area of prostate cancer screening, while a third, from Aidoc, targets incidental pulmonary embolism. Quantib's software delivers an in-workflow assessment of prostate...
Artificial intelligence, Thirona, Cystic Fibrosis
By  Sara Mageit 07:10 am October 16, 2020
Dutch AI medical image analysis company, Thirona has obtained a license on a patent for the treatment of Cystic Fibrosis (CF). The patent allows Thirona to develop an AI algorithm that will analyse CT scans to identify abnormalities in the lungs, ensuring that they are identified from an early age and that a personalised treatment plan can follow. WHY IT MATTERS Worldwide, there are approximately...
By  Tammy Lovell 08:17 am October 6, 2020
US tech giant NVIDIA has announced plans to build the UK’s most powerful supercomputer, to help healthcare researchers. The Cambridge-1 supercomputer is expected to come online by the end of the year and is intended for artificial intelligence (AI) research into medical challenges, including those presented by COVID-19. Speaking at his GPU Technology Conference keynote, NVIDIA founder and CEO,...
Sophia Genetics, artificial intelligence, funding, Swisscom Ventures
By  Tammy Lovell 08:39 am October 1, 2020
Swiss medical data specialist Sophia Genetics today announced the closing of a $110 million financing round to enter into the next stage of its expansion. The Series F round was led by aMoon, a health tech and life sciences venture fund based in Israel, and Hitachi Ventures, a venture arm of Japanese Hitachi Group. The company also received the trust of prime financial institutions Credit Suisse...
By  Mallory Hackett 11:36 am September 30, 2020
The artificial intelligence-enabled drug research and development startup XtalPi brought home nearly $319 million in its Series C funding round, announced Monday. SoftBank Vision Fund 2, PICC Capital and Morningside co-led the investment round, while Tencent, Sequoia China, China Life and SIG also made contributions. WHAT IT DOES Founded in 2014 by a group of quantum physicists at MIT, XtalPi...